ERBB2 and pulmonary fibrosis: Targeting HER2 using 2C4, a monoclonal antibody directed against HER2 that blocks HER2/HER3 signaling, attenuated bleomycin-induced pulmonary fibrosis in mice (Faress et al., 1985), although the potential mechanisms remained undiscovered.